Fluoxetina ou Hypericum perforatum no tratamento de pacientes portadores de transtorno depressivo maior leve a moderado: uma revisão

Chiovatto, Renato Davino; Fukuda, Ellen Yukie; Feder, David; Nassis, Cristina de Zotti.
Arq. bras. ciênc. saúde ; 36(3): 168-175, jan. 12. ilus, tab
Artigo Português | LILACS | ID: lil-613411

Documentos relacionados

  1. Antidepressant and Cardioprotective Effects of Self-Nanoemulsifying Self-Nanosuspension Loaded with Hypericum perforatum on Post-Myocardial Infarction Depression in Rats.
  2. Antidepressant polyprenylated acylphloroglucinols from <i>Hypericum ascyron</i>.
  3. St. John's Wort Herbal Teas - Biological Potential and Chemometric Approach to Quality Control.
  4. Depression and Its Phytopharmacotherapy-A Narrative Review.
  5. Impact of St. John's wort extract Ze 117 on stress induced changes in the lipidome of PBMC.
  6. Analysis of hyperforin (St. John's wort) action at TRPC6 channel leads to the development of a new class of antidepressant drugs.
  7. Medicinal Plants in the Treatment of Depression: Evidence from Preclinical Studies.
  8. Advances in Alternative and Integrative Medicine in the Treatment of Depression: A Review of the Evidence.
  9. Cellular neurobiology of hyperforin.
  10. Medicinal Plants in the Treatment of Depression. II: Evidence from Clinical Trials.